BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 6 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $73,151,908 | -21.5% | 1,456,629 | -1.2% | 0.24% | -18.7% |
| Q2 2023 | $93,187,768 | +91.4% | 1,474,490 | +36.2% | 0.30% | +75.9% |
| Q1 2023 | $48,699,381 | +8.5% | 1,082,449 | +5.6% | 0.17% | -1.2% |
| Q4 2022 | $44,888,339 | -36.6% | 1,024,614 | -4.6% | 0.17% | -38.6% |
| Q3 2022 | $70,785,000 | +31.6% | 1,074,284 | +0.9% | 0.28% | +40.7% |
| Q2 2022 | $53,800,000 | -22.4% | 1,065,128 | -1.9% | 0.20% | -3.9% |
| Q1 2022 | $69,343,000 | -63.0% | 1,085,516 | -37.9% | 0.21% | -59.1% |
| Q4 2021 | $187,198,000 | +6.0% | 1,747,721 | +1.8% | 0.51% | +1.6% |
| Q3 2021 | $176,542,000 | +93.7% | 1,717,164 | +65.8% | 0.50% | +74.1% |
| Q2 2021 | $91,119,000 | -11.5% | 1,035,918 | -2.2% | 0.29% | -14.4% |
| Q1 2021 | $102,993,000 | -6.6% | 1,059,271 | +7.8% | 0.33% | -9.0% |
| Q4 2020 | $110,223,000 | – | 982,814 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 716,539 | $36,192,000 | 12.35% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,020,629 | $102,062,000 | 6.89% |
| Casdin Capital, LLC | 1,150,000 | $58,087,000 | 4.91% |
| DAFNA Capital Management LLC | 261,280 | $13,197,000 | 3.60% |
| Nextech Invest Ltd. | 188,228 | $9,507,000 | 3.21% |
| Eagle Health Investments LP | 170,551 | $8,615,000 | 2.01% |
| Boxer Capital, LLC | 507,374 | $25,627,000 | 1.62% |
| Rock Springs Capital Management LP | 979,174 | $49,458,000 | 1.44% |
| EFG Asset Management (North America) Corp. | 130,454 | $6,589,000 | 1.39% |
| Integral Health Asset Management, LLC | 130,000 | $6,566,000 | 1.35% |